Molecular group:
Angiogenic and coagulation factors
Molecule/Cell:
EPO
Plasmodium strain:
Plasmodium chabaudi AS
pRBC infection titer:
10^6
Mouse genetic background (Con):
C57BL/6
Experimental treatment group (EG):
rmEpo
Lethal infection (Con):
no
Lethal infection (EG):
yes (% depended on the time of administration)
Pathology (Con):
N.I.
Pathology (EG):
SMA (% depended on the time of administration)
Parasitemia (EG vs Con):
Increased and delayed clearance
Additional phenotypes (EG vs Con):
Earlier increase in reticulocytosis
Refs:
Chang et al., 2004, J Infect Dis
Hyperlink: